238 related articles for article (PubMed ID: 9859072)
1. [Ecstasy: idiosyncrasy, overdosage or collateral effects].
Avila de Tomás JF
Med Clin (Barc); 1998 Oct; 111(13):517-8. PubMed ID: 9859072
[No Abstract] [Full Text] [Related]
2. [Toxicity of ecstasy].
Mas M; Farré M; Roset PN; Camí J
Med Clin (Barc); 1998 Oct; 111(13):516-7. PubMed ID: 9859071
[No Abstract] [Full Text] [Related]
3. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
Parrott A
Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
[No Abstract] [Full Text] [Related]
4. [Effects of ecstasy on the body].
Saarijärvi S; Lopperi M
Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
[No Abstract] [Full Text] [Related]
5. Transient haemolytic anaemia due to ecstasy in a patient on HAART.
Goorney BP; Scholes P
Int J STD AIDS; 2002 Sep; 13(9):651. PubMed ID: 12243137
[No Abstract] [Full Text] [Related]
6. [The new drugs: ecstasy, GHB. Update for practitioners].
Feldman N; Croquette-Krokar M
Rev Med Suisse Romande; 2001 Dec; 121(12):885-8. PubMed ID: 11803792
[No Abstract] [Full Text] [Related]
7. Methodological problems with ecstasy and the SCL-90.
Cole JC; Sumnall HR; Wagstaff GF
Psychopharmacology (Berl); 2002 Jul; 162(2):215-7; discussion 218-22. PubMed ID: 12110999
[No Abstract] [Full Text] [Related]
8. Ecstasy induced acute bilateral angle closure and transient myopia.
Kumar RS; Grigg J; Farinelli AC
Br J Ophthalmol; 2007 May; 91(5):693-5. PubMed ID: 17446512
[No Abstract] [Full Text] [Related]
9. [Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
Fortschr Neurol Psychiatr; 1999 Dec; 67(12):574-6. PubMed ID: 10683753
[No Abstract] [Full Text] [Related]
10. [Ecstasy].
Ege PP
Ugeskr Laeger; 2000 Jul; 162(31):4161-2. PubMed ID: 10962923
[No Abstract] [Full Text] [Related]
11. [Hepatitis from ecstasy].
Giner Durán R; Flors H; Millán M; Manzanera R
Gastroenterol Hepatol; 1998 Mar; 21(3):158. PubMed ID: 9607299
[No Abstract] [Full Text] [Related]
12. [New Drugs: Ectasy and Gamma-Hydroxy-Butyrate (GHB)].
Feldman N; Croquette-Krokar M
Vertex; 2002; 13(47):5-8. PubMed ID: 11967570
[TBL] [Abstract][Full Text] [Related]
13. [On ecstasy].
Boulu R
Ann Pharm Fr; 2003 May; 61(3):155-6. PubMed ID: 12714927
[No Abstract] [Full Text] [Related]
14. Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs.
O'Suilleabhain P; Giller C
Mov Disord; 2003 Nov; 18(11):1378-81. PubMed ID: 14639685
[TBL] [Abstract][Full Text] [Related]
15. Plasma amino acids in ecstasy users.
Stuerenburg HJ; Petersen K; Buhmann C; Rosenkranz M; Baeumer T; Thomasius R
Neuro Endocrinol Lett; 2003 Oct; 24(5):348-9. PubMed ID: 14647011
[TBL] [Abstract][Full Text] [Related]
16. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
Cohen RS
Biol Psychiatry; 1996 May; 39(9):819-20. PubMed ID: 8731525
[No Abstract] [Full Text] [Related]
17. ["Nice young people looking for fun". Interview by Dr. rer nat. Anita Schweiger].
Tretter F
Fortschr Med; 1997 Mar; 115(7):44-6. PubMed ID: 9173021
[No Abstract] [Full Text] [Related]
18. Ecstasy (MDMA) and oral health.
Brand HS; Dun SN; Nieuw Amerongen AV
Br Dent J; 2008 Jan; 204(2):77-81. PubMed ID: 18268544
[TBL] [Abstract][Full Text] [Related]
19. [MDMA--"ecstasy"].
Keup W
Med Monatsschr Pharm; 1996 Jan; 19(1):2-5. PubMed ID: 8583979
[No Abstract] [Full Text] [Related]
20. [MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects].
Prada C; Alvarez FJ
Med Clin (Barc); 1996 Oct; 107(14):549-55. PubMed ID: 8999216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
